Koru Pharma – Avalon Grand Plus

Description

AVALON Grand Plus is a non-surgical filler which contains highly-purified hyaluronic acid (24 mg/ml) and lidocaine (0.3%) for anaesthetic effects.
It is designed to be injected into the deep dermis for the correction of moderate to severe facial wrinkles and folds , cheeks, chin augmentation and shaping of the contours of the face and jawline.
The viscous filler, AVALON™ Grand Plus is an ideal solution for the correction of thick skin and deep wrinkles and it is also efficient in restoring volume with results lasting from 12 – 18 months*.

Cross-linked Hyaluronic Acid in AVALON™ Fillers

MCO™ Tech. (Minimising Cross-linking-agent by Optimising reaction Technology) is a technology developed by Koru Pharma’s R&D Institute.
The cross-linking agent serves to connect hyaluronic acid chains to form a net.
Through optimisation of cross-linking reaction conditions in which a chemical reaction between the cross-linking agent and HA occurs, the use of the cross-linking agent is minimised, thereby maximising the efficiency of the cross-linking reaction.

Indications

• Deep wrinkles
• Aesthetic defects in buccal, zygomatic, mandibular and nasal areas
• Volume loss in the zygomatic and nasal areas
• Undefined facial contours

Package

1 box / 1 syringe x 1 ml + 2 needles

*The duration of effect might vary depending on the individual physical characteristics of the patient, injection method and type of the procedure.